Pancreatic cancer risk and ABO blood group alleles: Results from the Pancreatic Cancer Cohort Consortium

Cancer Research

Volumn 70, Issue 3, 2010, Pages 1015-1023

  Wolpin, Brian M ^a,b   Kraft, Peter ^c   Gross, Myron ^f   Helzlsouer, Kathy ^g   Bueno de Mesquita, H Bas ^h,i   Steplowski, Emily ^j   Stolzenberg Solomon, Rachael Z ^k   Arslan, Alan A ^l,m   Jacobs, Eric J ⁿ   LaCroix, Andrea ^o   Petersen, Gloria ^p   Zheng, Wei ^p,r   Albanes, Demetrius ^k   Allen, Naomi E ^s   Amundadottir, Laufey ^k   Anderson, Garnet ^o   Boutron Ruault, Marie Christine ^t   Buring, Julie E ^b,d   Canzian, Federico ^u   Chanock, Stephen J ^k   Clipp, Sandra ^v   Gaziano, John Michael ^b,e   Giovannucci, Edward L ^b,c   Hallmans, Göran ^w   Hankinson, Susan E ^b,c   Hoover, Robert N ^k   Hunter, David J ^b,c   Hutchinson, Amy ^k,x   Jacobs, Kevin ^k,x,y   Kooperberg, Charles ^o   Lynch, Shannon M ^k   Mendelsohn, Julie B ^k   Michaud, Dominique S ^c,z   Overvad, Kim ^aa   Patel, Alpa V ⁿ   Rajkovic, Aleksandar ^ab   Sanchéz, Maria José ^ac   Shu, Xiao Ou ^q,r   Slimani, Nadia ^ad   Thomas, Gilles ^k   Tobias, Geoffrey S ^k   Trichopoulos, Dimitrios ^c,ae   Vineis, Paolo ^z   Virtamo, Jarmo ^af   Wactawski Wende, Jean ^ag   Yu, Kai ^k   Zeleniuch Jacquotte, Anne ^l,m   Fuchs, Patricia Hartge Charles S ^a,b   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g MERCY MEDICAL CENTER   (United States)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j INFORMATION MANAGEMENT SERVICES INC   (United States)

^k NATIONAL INSTITUTES OF HEALTH   (United States)

^l NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NEW YORK UNIVERSITY   (United States)

ⁿ AMERICAN CANCER SOCIETY   (United States)

^o Fred Hutchinson Cancer Research Center   (United States)

^p MAYO CLINIC   (United States)

^q VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^r VANDERBILT INGRAM CANCER CENTER   (United States)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t INSERM   (France)

^u GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^v George W Comstock Center for Public Health Research and Prevention   (United States)

^w UMEÅ UNIVERSITY   (Sweden)

^x SAIC FREDERICK INC   (United States)

^y Bioinformed Consulting Services   (United States)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa AALBORG UNIVERSITY HOSPITAL   (Denmark)

^ab BAYLOR COLLEGE OF MEDICINE   (United States)

^ac ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ad INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ae UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^af NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ag UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; SEROLOGY; SMOKING;

ABO BLOOD-GROUP SYSTEM; AGED; ALLELES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 76249122015     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2993     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006;20:1218-49.
3. Owen R. Karl Landsteiner and the first human marker locus. Genetics 2000;155:995-8.
4. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-33.
5. Yamamoto F, Marken J, Tsuji T, White T, Clausen H, Hakomori S. Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc α1→2Gal α1→3GalNAc transferase (histo-blood group A transferase) mRNA. J Biol Chem 1990;265:1146-51.
6. Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol 2004;41:93-117.
7. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999;1473:247-66.
8. Hoskins LC, Loux HA, Britten A, Zamcheck N. Distribution of ABO blood groups in patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated with pernicious anemia. N Engl J Med 1965;273:633-7.
9. Vogel F. Controversy in human genetics. ABO blood groups and disease. Am J Hum Genet 1970;22:464-75.
10. Aird I, Lee DR, Roberts JA. ABO blood groups and cancer of oesophagus, cancer of pancreas, and pituitary adenoma. Br Med J 1960;1:1163-6.
11. Newell GR, Gordon JE, Monlezun AP, Horwitz JS. ABO blood groups and cancer. J Natl Cancer Inst 1974;52:1425-30.
12. Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R. ABO blood groups and cancer of the pancreas. Int J Pancreatol 1990;6:81-8.
13. Vioque J, Walker AM. Pancreatic cancer and ABO blood types: a study of cases and controls. Med Clin (Barc) 1991;96:761-4.
14. Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-31.
15. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90.
16. Pare G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008;4:e1000118.
17. Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005;28:261-72.
18. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9.
19. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia: Lippincott, Williams & Wilkins; 2008.
20. Gail MH. In: Rebbeck TR, Ambrosone CB, Shields PG, editors. Models of absolute risk: interpretation, estimation, validation and application, in molecular epidemiology: applications in cancer and other human diseases. New York: Informa Healthcare; 2008.
21. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
22. Blumenfeld OO, Patnaik SK. Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004;23:8-16.
23. Garratty G, Glynn SA, McEntire R. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 2004;44:703-6.
24. Yip SP. Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles. Blood 2000;95:1487-92.
25. Gassner C, Schmarda A, Nussbaumer W, Schonitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood 1996;88:1852-6.
26. Marcus DM. The ABO and Lewis blood-group system. Immunochemistry, genetics and relation to human disease. N Engl J Med 1969;280:994-1006.
27. Hakomori S. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 2001;491:369-402.
28. Garcea G, Dennison AR, Steward WP, Berry DP. Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology 2005;5:514-29.
29. Guerra C, Schuhmacher AJ, Canamero M, et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007;11:291-302.
30. Melzer D, Perry JR, Hernandez D, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008;4:e1000072.
31. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-86.
32. Zollner S, Pritchard JK. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet 2007;80:605-15.
33. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000;92:1151-8.
34. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:37.